Investing.com - Financial Markets Worldwide

Genincode PLC (GENIG)

London
Currency in GBP
1.40
0.00(0.00%)
Closed·
GENIG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GENIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
1.301.50
52 wk Range
1.008.50
Key Statistics
Edit
Bid/Ask
1.20 / 1.60
Prev. Close
1.4
Open
1.4
Day's Range
1.3-1.5
52 wk Range
1-8.5
Volume
66.7K
Average Volume (3m)
435.06K
1-Year Change
-79.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENIG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
RSI suggests the stock is in oversold territory
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Genincode PLC Company Profile

GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company’s invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a genetic test to help user to adopt cardiovascular prevention assesment; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia FH; SUDD inCode, genetic diagnostic test for familial heart diseases; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, is a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and ROCA Test, a blood test that determines the risk of a woman having ovarian cancer. Further, it engages in the medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
42
Market
United Kingdom

Compare GENIG to Peers and Sector

Metrics to compare
GENIG
Peers
Sector
Relationship
P/E Ratio
−0.9x−1.0x−0.5x
PEG Ratio
−0.010.000.00
Price/Book
3.6x1.2x2.6x
Price / LTM Sales
1.5x0.9x3.2x
Upside (Analyst Target)
-41.3%38.8%
Fair Value Upside
Unlock19.4%5.4%Unlock

Earnings

Latest Release
Jun 04, 2025
EPS / Forecast
-0.01 / -0.0151
Revenue / Forecast
1.31M / 2.04M
EPS Revisions
a
a
Unlock
Last 90 days

GENIG Income Statement

FAQ

What Stock Exchange Does Genincode Trade On?

Genincode is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Genincode?

The stock symbol for Genincode is "GENIG."

What Is the Genincode Market Cap?

As of today, Genincode market cap is 4.02M.

What Is Genincode's Earnings Per Share (TTM)?

The Genincode EPS (TTM) is -0.03.

When Is the Next Genincode Earnings Date?

Genincode will release its next earnings report on 23 Sept 2025.

From a Technical Analysis Perspective, Is GENIG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genincode Stock Split?

Genincode has split 0 times.

How Many Employees Does Genincode Have?

Genincode has 42 employees.

What is the current trading status of Genincode (GENIG)?

As of 31 Aug 2025, Genincode (GENIG) is trading at a price of 1.40, with a previous close of 1.40. The stock has fluctuated within a day range of 1.30 to 1.50, while its 52-week range spans from 1.00 to 8.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.